The purpose of this study is to learn more about the tolerability and safety of a daily immunotherapy tablet (SLIT-tablet) for people with peanut allergies. The goal of the SLIT-tablet is to increase tolerance to peanut protein, which could reduce the risk of allergic reactions caused by accidental exposure.
Thank you for your interest, but this study is not currently enrolling.
North Carolina (Statewide)
Edwin Kim
Pediatrics - Allergy Immunology and Rheumatology
Clinical or Medical
Interventional
Chronic Conditions
Immune System/Infections
22-1338
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
